Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
T cell developmental arrest in former premature infants increases risk of respiratory morbidity later in infancy
Kristin M. Scheible, … , Thomas J. Mariani, Gloria S. Pryhuber
Kristin M. Scheible, … , Thomas J. Mariani, Gloria S. Pryhuber
Published February 22, 2018
Citation Information: JCI Insight. 2018;3(4):e96724. https://doi.org/10.1172/jci.insight.96724.
View: Text | PDF
Research Article Development Immunology

T cell developmental arrest in former premature infants increases risk of respiratory morbidity later in infancy

  • Text
  • PDF
Abstract

The inverse relationship between gestational age at birth and postviral respiratory morbidity suggests that infants born preterm (PT) may miss a critical developmental window of T cell maturation. Despite a continued increase in younger PT survivors with respiratory complications, we have limited understanding of normal human fetal T cell maturation, how ex utero development in premature infants may interrupt normal T cell development, and whether T cell development has an effect on infant outcomes. In our longitudinal cohort of 157 infants born between 23 and 42 weeks of gestation, we identified differences in T cells present at birth that were dependent on gestational age and differences in postnatal T cell development that predicted respiratory outcome at 1 year of age. We show that naive CD4+ T cells shift from a CD31–TNF-α+ bias in mid gestation to a CD31+IL-8+ predominance by term gestation. Former PT infants discharged with CD31+IL8+CD4+ T cells below a range similar to that of full-term born infants were at an over 3.5-fold higher risk for respiratory complications after NICU discharge. This study is the first to our knowledge to identify a pattern of normal functional T cell development in later gestation and to associate abnormal T cell development with health outcomes in infants.

Authors

Kristin M. Scheible, Jason Emo, Nathan Laniewski, Andrea M. Baran, Derick R. Peterson, Jeanne Holden-Wiltse, Sanjukta Bandyopadhyay, Andrew G. Straw, Heidie Huyck, John M. Ashton, Kelly Schooping Tripi, Karan Arul, Elizabeth Werner, Tanya Scalise, Deanna Maffett, Mary Caserta, Rita M. Ryan, Anne Marie Reynolds, Clement L. Ren, David J. Topham, Thomas J. Mariani, Gloria S. Pryhuber

×

Figure 6

CD31–CD4+ T cell fractions show a similar pattern of increased proliferation and homeostatic cytokine receptor expression compared with CD31+ T cells in both age cohorts.

Options: View larger image (or click on image) Download as PowerPoint
CD31–CD4+ T cell fractions show a similar pattern of increased prolifera...
Infants <29 weeks have greater proliferation and decreased memory differentiation of both CD31+ and CD31– fractions compared with infants born older than 29 weeks. Line graphs compare subject-matched CD4+CD31+ to CD31– T cell expression of (A) Ki67, (B) CD45RO, (C) CD127, and (D) CD215. Light gray lines indicate subjects born <29 weeks and dark indicates subjects born ≥29 weeks (*P < 0.05, **P < 0.01,***P < 0.001, ****P < 0.0001, Wilcoxon matched-pairs signed-rank test).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts